📰 Arthur Roach News
Arthur Roach News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arthur Roach. Real-time updates on events, politics, business and more.
April 27, 2024
Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s.
July 7, 2023
The findings are being revealed at the World Parkinson’s Congress in Barcelona, Spain.
July 7, 2023
The findings are being revealed at the World Parkinson’s Congress in Barcelona, Spain.
July 7, 2023
The findings are being revealed at the World Parkinson’s Congress in Barcelona, Spain.
July 6, 2023
The findings are being revealed at the World Parkinson’s Congress in Barcelona, Spain.
July 6, 2023
The findings are being revealed at the World Parkinson’s Congress in Barcelona, Spain.
October 13, 2022
PHILADELPHIA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing...
September 1, 2022
ASX Health Stocks: Pharmaxis gets $5m to fund groundbreaking collaboration study of lead drug PXS‐4728
September 1, 2022
“This study provides hope for an effective treatment and a step towards the longer-term goal of stopping neurodegeneration,” said Pharmaxis...
August 23, 2022
/PRNewswire/ -- The Parkinsons Foundation and Parkinsons UK, an organization based in the United Kingdom that funds research and provides life-changing...